ArticleResearch square2025
CHD3 and CHD4 coordinate gene expression programs to maintain β-cell function and identity
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Pancreatic β cells require tightly regulated chromatin architecture to preserve their identity and sustain glucose-stimulated insulin secretion. Here, we define cooperative and compensatory roles for the NuRD complex remodelers CHD3 and CHD4 in maintaining β-cell function. While β-cell-specific loss of CHD3 alone had little effect, combined deletion of CHD3 and CHD4 caused severe glucose intolerance, impaired insulin secretion, and reduced β-cell area. Transcriptomic and chromatin accessibility analyses revealed downregulation of key β-cell maturity genes, reduced accessibility at β-cell enhancers, and derepression of disallowed, developmental, and alternative islet cell programs, accompanied by altered ion channel expression and defective electrophysiological properties. Mechanistically, CHD3 protein abundance increased upon CHD4 loss and CHD3:PDX1 interactions were dynamically enhanced during early high-fat diet challenge, buffering against β-cell stress before collapsing under chronic conditions. Human pseudoislets recapitulated conserved features of CHD3/4 deficiency, linking these remodelers to human β-cell function. Together, our findings establish CHD3 and CHD4 as cooperative guardians of β-cell transcriptional programs and uncover a compensatory mechanism that transiently preserves β-cell resilience under metabolic stress but fails in diabetes progression.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.